Ultrasonographic Evaluation of Ovarian Stromal Vascularity in Women With Polycystic Ovary Syndrome (PCOS)
NCT05418595 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42
Last updated 2022-09-21
Summary
The most common endocrine condition in reproductive women is polycystic ovary syndrome. It has a prevalence of 5-10%. According to the Rotterdam criteria, oligo/anovulation, clinic or biochemical hyperandrogenism, PCOS morphology in ultrasonography, and the presence of these two criteria are required for diagnosis.
The echogenicity of the ovarian stroma, vascularity, ovarian size, cystic pattern density, and subcortical organization of cysts are all significant considerations in ultrasonographic evaluation.
Conditions
- Ovarian Cysts
Interventions
- OTHER
-
Sponsors & Collaborators
-
Usak State Hospital
lead OTHER
Principal Investigators
-
İrem Şenyuva, MD · USAK TRAINING AND RESEARCH HOSPITAL, DEPARTMENT OF OBSTETRICS AND GYNECOLOGY,TURKEY
Eligibility
- Min Age
- 18 Years
- Max Age
- 38 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-06-13
- Primary Completion
- 2022-09-04
- Completion
- 2022-09-04
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Ultrasound Three-dimensional Characterization of Ovarian Morphology in Women With Polycystic Ovary Syndrome (PCOS)
NCT02402413 ·Status: UNKNOWN ·Phase: NA
-
Uterine and Endometrial Volume in PCOS and HPOD
NCT06211608 ·Status: COMPLETED
-
The Effect of Polycystic Ovary Syndrome on Pelvic Floor Structure and Function
NCT04398186 ·Status: COMPLETED
-
Polycystic Ovary Syndrome and BETATROPHIN
NCT04448730 ·Status: COMPLETED
-
Phenotyping of Patients With Polycystic Ovary Syndrome
NCT07339930 ·Status: RECRUITING
-
Serum Anti-Mullerian Hormone (AMH) Levels in Overweight and Obese Adolescent Girls With Polycystic Ovaries
NCT01856894 ·Status: COMPLETED
-
Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
NCT05843955 ·Status: COMPLETED
-
Ovarian Innervation Study in Patients With Polycystic Ovary Syndrome (PCOS)
NCT05966571 ·Status: UNKNOWN
-
The Effect of Polycystic Ovary Syndrome on the Embryo Morphokinetics ( PCOS )
NCT05438355 ·Status: COMPLETED
-
Anxiety and Depression in Adolescent PCOS
NCT07127458 ·Status: COMPLETED ·Phase: NA
-
PCOS Twin Study - Environmental Factors in the Development of Polycystic Ovary Syndrome, Phase 2
NCT00444288 ·Status: COMPLETED
-
Ultrasonographic Evaluation of Anovulatory Disorders in Lean and Overweight Women
NCT03306849 ·Status: COMPLETED
-
History of Polycystic Ovary Syndrome in First-degree Relatives
NCT06442228 ·Status: COMPLETED ·Phase: NA
-
The Use Of AMH for the Discrimination of Polycystic and Multicystic Ovaries in Nonhyperandrogenic Patients
NCT01878955 ·Status: UNKNOWN
-
PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease
NCT07146815 ·Status: COMPLETED ·Phase: NA
-
Epicardial Adipose Tissue Thickness in Polycystic Ovary Syndrome (PCOS)
NCT01258946 ·Status: COMPLETED
-
Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using Fibroscan
NCT07027332 ·Status: COMPLETED
-
Intrauterine Environment in Polycystic Ovary Syndrome (PCOS) Probands
NCT00364949 ·Status: COMPLETED
-
Subcutaneous Adipose Tissue in Cases With Polycystic Ovarian Syndrome
NCT01310569 ·Status: COMPLETED
-
To Study Polycystic Ovary Syndrome in Taiwanese Women
NCT01256944 ·Status: COMPLETED
-
Hepassocin Levels in Patients With Polycystic Ovary Syndrome
NCT04369248 ·Status: COMPLETED
-
Visceral Adiposity Index Differences Between Subtypes of Polycystic Ovary Syndrome
NCT06358300 ·Status: COMPLETED
-
Comparison Between Laparoscopic Ovarian Diathermy and Clomiphene Citrate in Women With Anovulatory PCOS
NCT00220545 ·Status: COMPLETED ·Phase: NA
-
The Effect of Polycystic Ovary Syndrome Phenotypes on Quality of Life and Sexual Function
NCT06428786 ·Status: COMPLETED
-
Metabolic Differences Between Subtypes of Polycystic Ovary Syndrome
NCT06342180 ·Status: COMPLETED